This article is more than 5 years old. Information may no longer be current.
Memorial Sloan Kettering Cancer Center names chair of neurosurgery
Click Here to Manage Email Alerts
Viviane Tabar, MD, has been appointed chair of the department of neurosurgery at Memorial Sloan Kettering Cancer Center.
She will succeed Philip Gutin, MD, who will retire at the end of this year.
Tabar, who has been on the institution’s faculty for more than 15 years, serves as Theresa C. Feng chair for neurosurgical oncology and vice chair for neurosurgical research and education.
Tabar specializes in intraoperative brain mapping techniques, which allow brain tumors to be removed more precisely. This spares as much surrounding tissue as possible.
“Dr. Tabar has contributed significantly to Memorial Sloan Kettering since she began her career here, first as a fellow and then after joining the faculty in 2002,” José Baselga, MD, PhD, Memorial Sloan Kettering’s physician-in-chief, said in a press release. “She is a world-renowned leader in neurosurgical treatment, research and education, and [she is] the ideal physician to lead this esteemed department. Dr. Tabar approaches the most complex surgical cases with confidence, dedication, and compassion for her patients and will bring that same level of excellence to this new role.”
Tabar also is founding director of the Multidisciplinary Pituitary and Skull Base Tumor Center at Memorial Sloan Kettering. This venture involves specialists in neurosurgery, head and neck surgery, and neuroendocrinology to serve patients with a variety of tumors and disorders.
“Memorial Sloan Kettering represents the very best in comprehensive treatment of brain, spine, and skull base tumors,” Tabar said in the release. “I am honored to begin leading this group of unsurpassed neurosurgery experts. Our focus will continue to be on providing our patients with the highest level of care and striving for innovative and more effective surgical therapies.”